Abstract
Objective
Design
Setting
Participants
Results
Conclusion
Keywords
List of abbreviations:
AM-PAC (Activity Measure for Post-Acute Care), ECMO (extracorporeal membrane oxygenation), FSS ICU (Functional Status Score for the ICU), ICU (intensive care unit), LUMC (Loyola University Medical Center)World Health Organization. WHO director-general's opening remarks at the media briefing on COVID-19. Available at: www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-11-march-2020. Accessed May 16, 2021.
Galiatsatos P. What coronavirus does to the lungs. Available at: https://www.hopkinsmedicine.org/health/conditions-and-diseases/coronavirus/what-coronavirus-does-to-the-lungs. Accessed May 17, 2021.
Methods
Data collection
US Centers for Medicare and Medicaid Services. Skilled Nursing Facility (SNF) care. Available at: https://www.medicare.gov/coverage/skilled-nursing-facility-snf-care. Accessed June 24, 2022.
US Centers for Medicare and Medicaid Services. Inpatient Rehabilitation care. Available at: https://www.medicare.gov/coverage/inpatient-rehabilitation-care. Accessed June 24, 2022.
Statistical analysis

Results
Factor | All, N=432 No. (%) | No Therapy, No ICU N=171 No. (%) | No Therapy, ICU N=96 No. (%) | Therapy, No ICU N=54 No. (%) | Therapy, ICU, N=111 No. (%) |
Age, mean±SD | 58 (16) | 54 (16) | 61 (16) | 68 (16) | 58 (15) |
Male | 238 (55) | 92 (54) | 57 (59) | 26 (48) | 63 (57) |
Race | |||||
White | 202 (47) | 77 (45) | 46 (48) | 19 (35) | 60 (54) |
Black | 120 (28) | 50 (29) | 25 (26) | 22 (41) | 23 (21) |
Other | 108 (25) | 43 (25) | 25 (26) | 13 (24) | 27 (25) |
Hispanic | 210 (50) | 89 (53) | 50 (55) | 13 (25) | 58 (54) |
Chronic lung disease | 73 (17) | 28 (17) | 15 (16) | 13 (25) | 17 (16) |
Diabetes | 197 (47) | 66 (40) | 46 (51) | 28 (53) | 57 (52) |
Cardiovascular disease | 287 (68) | 96 (57) | 69 (76) | 46 (87) | 76 (69) |
Renal disease | 77 (18) | 24 (14) | 17 (19) | 12 (23) | 24 (22) |
Liver disease | 23 (5) | 8 (5) | 6 (7) | 5 (9) | 4 (4) |
Immunosuppressive comorbidity | 42 (10) | 17 (10) | 11 (12) | 4 (8) | 10 (9) |
Neurologic comorbidity | 56 (13) | 14 (8) | 16 (17) | 10 (19) | 16 (15) |
Cancer | 33 (8) | 11 (7) | 8 (9) | 8 (15) | 6 (6) |
Current smoker | 17 (5) | 7 (5) | 0 (0) | 4 (8) | 6 (6) |
Therapy Details | All, N=165 No. (%) | Therapy, No ICU, N=54 No. (%) | Therapy, ICU, N=111 No. (%) |
---|---|---|---|
OT frequency | |||
None | 29 (18) | 16 (30) | 13 (12) |
1-4×/wk | 82 (50) | 33 (61) | 49 (44) |
4-5×/wk, 1-3×/d | 54 (33) | 5 (9) | 49 (44) |
PT frequency | |||
None | 8 (5) | 4 (7) | 4 (4) |
1-4×/wk | 60 (36) | 27 (50) | 33 (30) |
4-5×/wk, 1-3×/d | 97 (59) | 23 (43) | 74 (67) |
Impairment | |||
Impaired cognition | 97 (59) | 23 (43) | 74 (67) |
Impaired strength | 113 (68) | 30 (56) | 83 (75) |
Impaired proximal strength | 102 (64) | 25 (48) | 77 (72) |
Impaired distal strength | 79 (50) | 19 (37) | 60 (56) |
Impaired balance | 144 (87) | 48 (89) | 96 (86) |
Impaired activity tolerance | 158 (96) | 50 (94) | 108 (97) |
Impaired sensation | 18 (11) | 9 (17) | 9 (8) |
Impaired coordination | 57 (35) | 15 (28) | 42 (38) |
Impaired proprioception | 12 (7) | 3 (6) | 9 (8) |
Therapy recommended at discharge | 123 (76) | 37 (71) | 86 (78) |
Group | Measure | Pre, Mean±SD | Post, Mean±SD | Difference (Post−Pre), Mean±SD |
---|---|---|---|---|
Therapy, no ICU | AM-PAC Basic Mobility, raw | 17.1 (4.3), n=51 | 17.9 (4.1), n=36 | 1.0 (2.3), n=35 |
AM-PAC Basic Mobility, t-Scale Score | 43.3 (7.9), n=51 | 44.8 (8.0), n=36 | 2.0 (4.9), n=35 | |
AM-PAC Daily Activity, raw | 17.1 (3.9), n=42 | 16.7 (3.7), n=18 | 0.7 (2.0), n=18 | |
AM-PAC Daily Activity, t-Scale Score | 37.9 (6.6), n=42 | 37.2 (5.7), n=18 | 1.2 (3.4), n=18 | |
Therapy, ICU | FSS-ICU | 9.0 (7.3), n=82 | 10.6 (6.6), n=67 | 2.5 (5.6), n=66 |
AM-PAC Basic Mobility, raw | 14.1 (5.4), n=79 | 16.7 (5.7), n=72 | 2.8 (3.9), n=69 | |
AM-PAC Basic Mobility, t-Scale Score | 38.4 (9.6), n=79 | 43.3 (10.7), n=72 | 5.2 (7.2), n=69 | |
AM-PAC Daily Activity, raw | 15.4 (4.3), n=65 | 16.4 (4.0), n=51 | 1.2 (3.3), n=48 | |
AM-PAC Daily Activity, t-Scale Score | 35.7 (7.3), n=65 | 36.8 (7.0), n=51 | 1.6 (5.4), n=48 |
Factor | All, N=432 No. (%) | No Therapy, No ICU N=171 No. (%) | No Therapy, ICU N=96 No. (%) | Therapy, No ICU N=54 No. (%) | Therapy, ICU, N=111 No. (%) |
---|---|---|---|---|---|
Ever mechanically ventilated | 144 (33) | — | 64 (67) | — | 80 (72) |
If ever mechanically ventilated, total d median (Q1, Q3) | 12 (5, 22) | — | 10 (4, 17) | — | 13.5 (6, 23.5) |
Ever on ECMO | 6 (1) | — | 0 (0) | — | 6 (5) |
If ever on ECMO, total d, median (Q1, Q3) | 2.5 (1, 5) | — | — | — | 2.5 (1, 5) |
Ever paralyzed with neuromuscular blockade | 77 (37) | — | 35 (36) | — | 42 (38) |
If ever paralyzed, total d, median (Q1, Q3) | 3 (1, 6) | — | 2 (1, 6) | — | 3 (2, 6) |
Length of stay, median (Q1, Q3) | 7 (3, 17) | 3 (2, 5) | 10 (6, 18) | 6 (3, 9) | 22 (13.5, 37) |
Died in hospital | 82 (19) | 1 (1) | 61 (64) | 1 (2) | 19 (17) |
Discharge location | |||||
| 261 (75) | 161 (95) | 24 (69) | 36 (68) | 40 (43) |
| 15 (4) | 7 (4) | 4 (4) | 3 (6) | 1 (1) |
| 50 (14) | 1 (1) | 1 (3) | 14 (26) | 34 (37) |
| 24 (7) | 1 (1) | 6 (17) | 0 (0) | 17 (18) |
Discussion
Limitations
Conclusions
Centers for Disease Control and Prevention. Post-COVID conditions. Available at: https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects.html. Accessed May 16, 2021.
Supplier
- •What is Known: Severe illness and prolonged hospitalization can lead to functional impairments. Access to rehabilitation in the acute care can promote positive functional outcomes. Limited research exists for patients with coronavirus disease 2019 (COVID-19).
- •What is New: Patients with COVID-19 receiving rehabilitation services in the intensive care unit (ICU) were more likely to have impaired cognition, strength, and sensation compared to non-ICU patients. Seventy-six percent of patients with COVID-19 evaluated by therapy were recommended to receive rehabilitation services at discharge. Patients with COVID-19 in the ICU who received rehabilitation services were able to reach the same functional level as non-ICU patients at discharge from the hospital.
References
- Inpatient rehabilitation outcomes after severe COVID-19 infections.Am J Phys Med Rehabil. 2021; 100: 1109-1114
- Effectiveness of pulmonary rehabilitation in severe and critically ill COVID-19 patients: a controlled study.Int J Environ Res Public Health. 2021; 18: 8956
Centers for Disease Control and Prevention. Post-COVID conditions. Available at: https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects.html. Accessed May 16, 2021.
Galiatsatos P. What coronavirus does to the lungs. Available at: https://www.hopkinsmedicine.org/health/conditions-and-diseases/coronavirus/what-coronavirus-does-to-the-lungs. Accessed May 17, 2021.
- Measuring discharge outcomes, length of stay, and functional ADL score during COVID-19 in inpatient rehabilitation hospitals.Arch Phys Med Rehabil. 2021; 102: 2291-2299
- Effectiveness of multicomponent nonpharmacological delirium interventions: a meta-analysis.JAMA Intern Med. 2015; 175: 512-520
- Functional Status Score for the Intensive Care Unit (FSS-ICU): an international clinimetric analysis of validity, responsiveness, and minimal important difference.Crit Care Med. 2017; 44: 1155-1164
- Validity of the AM-PAC “6 Clicks” Inpatient Daily Activity and Basic Mobility Short Forms.Phys Ther. 2014; 94: 379-391
- Frequency of physical therapist intervention is associated with mobility status and disposition at hospital discharge for patients with COVID-19.Phys Ther. 2021; 101: 1-8
- Challenges and lessons learned for acute inpatient rehabilitation of persons with COVID-19: clinical presentation, assessment, needs, and services utilization.Am J Phys Med Rehabil. 2021; 100: 1115-1123
- Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China.JAMA Neurol. 2020; 77: 1-9
- Characterizing non-critically ill COVID-19 survivors with and without in-hospital rehabilitation.Sci Rep. 2021; 11: 21039-21050
- Functional status of mechanically ventilated COVID-19 survivors at ICU and hospital discharge.J Intens Care. 2021; 9: 31-40
- Patient characteristics and acute PT and OT utilization during the initial surge of COVID-19: a retrospective observational study.J Acute Care Phys Ther. 2022; 13: 2-7
- Physical impairments associated with post-intensive care syndrome: systematic review based on the World Health Organization's International Classification of Functioning, Disability and Health framework.Phys Ther. 2018; 2098: 631-645
- Identification of functional limitations and discharge destination in patients with COVID-19.Arch Phys Med and Rehab. 2021; 102: 351-358
- Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial.Lancet. 2009; 373: 1874-1882
- Rehabilitation challenges in COVID-19 induced acute polyradiculoneuropathies.Balneo and PRM Research Journal. 2021; 12: 94-98
- Cognitive stimulation and occupational therapy for delirium prevention.Rev Bras Ter Intensiva. 2017; 29: 248-252
- The use of physical therapy ICU assessments to predict discharge home.Crit Care Med. 2020; 48: 1312-1318
US Centers for Medicare and Medicaid Services. Skilled Nursing Facility (SNF) care. Available at: https://www.medicare.gov/coverage/skilled-nursing-facility-snf-care. Accessed June 24, 2022.
US Centers for Medicare and Medicaid Services. Inpatient Rehabilitation care. Available at: https://www.medicare.gov/coverage/inpatient-rehabilitation-care. Accessed June 24, 2022.
- Association of AM-PAC “6-Clicks” Basic Mobility and Daily Activity scores with discharge destination.Phys Ther. 2021; 101: 1-9
World Health Organization. WHO director-general's opening remarks at the media briefing on COVID-19. Available at: www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-11-march-2020. Accessed May 16, 2021.
Article info
Publication history
Footnotes
Funding for Loyola University's COVID-19 Registry for Organizing Chicagoland Area Research for Health Equity and Community Services (CRO CARES) and statistical support for this project were provided by Loyola University Chicago's Health EQ Collaborative.
Disclosures: none.